FDA Inspection 1116404 — Biomet, Inc.

Biomet, Inc. — FEI 1825034

The FDA completed an inspection of Biomet, Inc. on Jan 30, 2020 in Warsaw, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 8 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 30, 2020
Fiscal Year
2020
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Warsaw, IN (United States)

Citations

IDCFRDescription
237121 CFR 820.30(a)Design control - no procedures
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces
312321 CFR 820.80(c)Lack of or inadequate In-process acceptance procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
368021 CFR 820.70(a)Process control procedures, Lack of or inadequate procedures
54121 CFR 820.70(c)Environmental control Lack of or inadequate procedures
54621 CFR 820.75(a)Lack of or inadequate process validation

Need the full FDA record for Biomet, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.